EconPapers    
Economics at your fingertips  
 

Single urinary extracellular vesicle proteomics identifies complement receptor CD35 as a biomarker for sepsis-associated acute kidney injury

Ning Li, Tao-Tao Tang, Menglei Gu, Yu-Qi Fu, Wei-Wei Qian, Nan Nan Ma, An-Ran Shen, Tingting Zhu, Run-Bo Huo, Tao Zhang, Jian-Feng Xie, Lu Zhang, Bi-Cheng Liu and Lin-Li Lv ()
Additional contact information
Ning Li: Zhong Da Hospital
Tao-Tao Tang: Zhong Da Hospital
Menglei Gu: Jiangsu Province Hospital of Chinese Medicine
Yu-Qi Fu: Zhong Da Hospital
Wei-Wei Qian: The Second Affiliated Hospital of Anhui Medical University
Nan Nan Ma: The Second Affiliated Hospital of Anhui Medical University
An-Ran Shen: Zhong Da Hospital
Tingting Zhu: Zhong Da Hospital
Run-Bo Huo: Zhongda Hospital
Tao Zhang: The Second Affiliated Hospital of Anhui Medical University
Jian-Feng Xie: Zhongda Hospital
Lu Zhang: Jiangsu Province Hospital of Chinese Medicine
Bi-Cheng Liu: Zhong Da Hospital
Lin-Li Lv: Zhong Da Hospital

Nature Communications, 2025, vol. 16, issue 1, 1-18

Abstract: Abstract Sepsis-associated acute kidney injury (SA-AKI) portends severe health burden due to significant morbidity and mortality, while early diagnosis remains challenging. In this study, proximity-dependent barcoding assay (PBA) is established to profile the surface proteome of single urinary extracellular vesicle (uEV). Principle uEV clusters with unique function and origination are profiled in SA-AKI in a screening cohort. Complement receptor CD35 on single uEV (CD35-uEV) displays high diagnostic accuracy for SA-AKI (AUC-ROC 0.89 in validation cohort, n = 134). Besides, CD35-uEV enables identification of subclinical AKI (AUC-ROC 0.84 in prospective cohort, n = 72). Moreover, CD35-uEV correlates closely with AKI severity which also predicts persistent AKI (AUC-ROC 0.77), mortality risks (AUC-ROC 0.70) and progression to AKD (AUC-ROC 0.66). Multi-omics profiling reveals that CD35-uEV are predominantly released from injured podocytes exhibiting diminished CD35 expression. Overall, this study identifies a single uEV biomarker related to injured podocyte for early diagnosis and risk stratification of SA-AKI.

Date: 2025
References: Add references at CitEc
Citations:

Downloads: (external link)
https://www.nature.com/articles/s41467-025-62229-4 Abstract (text/html)

Related works:
This item may be available elsewhere in EconPapers: Search for items with the same title.

Export reference: BibTeX RIS (EndNote, ProCite, RefMan) HTML/Text

Persistent link: https://EconPapers.repec.org/RePEc:nat:natcom:v:16:y:2025:i:1:d:10.1038_s41467-025-62229-4

Ordering information: This journal article can be ordered from
https://www.nature.com/ncomms/

DOI: 10.1038/s41467-025-62229-4

Access Statistics for this article

Nature Communications is currently edited by Nathalie Le Bot, Enda Bergin and Fiona Gillespie

More articles in Nature Communications from Nature
Bibliographic data for series maintained by Sonal Shukla () and Springer Nature Abstracting and Indexing ().

 
Page updated 2025-07-31
Handle: RePEc:nat:natcom:v:16:y:2025:i:1:d:10.1038_s41467-025-62229-4